PEMETREXED | N208419 | ACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| S.D. Ind. | 2017-03-30 | Terminated 2018-05-29 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lachman Consulant Services, Inc. - Citizen Petition FDA-2011-P-0052 · 6 docket documents Lachman Consultant Services, Inc. filed this petition on January 18, 2011, pursuant to Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act, requesting that the FDA declare Pemetrexed for Injection, 1000 mg suitable for submission as an abbreviated new drug application. The petitioner see | Other | 2011-02-08 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.